Kone (KNEBV.HEX)

Close: 71.88 (+1.30), Apr 16, 2021
Hold

Low risk

Automatic technical analysis. Medium term, Apr 16, 2021

Kone has broken the rising trend up in the medium long term. This signals an even stronger rate of growth, but the positive development may result in corrections down in the short term. The stock is approacing resistance at 73.30 euro, which may give a negative reaction. However, a break upwards through 73.30 euro will be a positive signal. The stock is assessed as technically neutral for the medium long term.

Recommendation one to six months: Hold (Score: 23)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.06%53.46+1.84%
5 days44.653.40%40.83+1.04%
22 days-11.188.95%44.50+8.09%
66 days-13.4220.24%47.96+13.27%

More analyses of Kone

chart Kone (KNEBV) Candlesticks 22 Days
Candlesticks
chart Kone (KNEBV) Short term
Short term: Positive
chart Kone (KNEBV) Medium term
Medium term: Hold
chart Kone (KNEBV) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK